Biologics, engineered for better control

At TROYA, we use protein engineering to control the activity of medicines, improving their potency and safety.

Our biotherapeutics platform is based on a novel, natural scaffold that effectively activates the drug at the disease site – sparing other parts of the body.

Contact us

Austin W. Boesch, PhD

Christoffer K. Goth, PhD

Seandean L. Harwood, PhD

Viktor T. Lemgart, PhD

Ulrik B. Nielsen, PhD